Nanomaterials to Resolve Atherosclerosis
Author:
Funder
American Heart Association
Publisher
American Chemical Society (ACS)
Subject
Biomedical Engineering,Biomaterials
Link
https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.0c00281
Reference128 articles.
1. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
2. Atherosclerosis
3. Immunity, atherosclerosis and cardiovascular disease
4. The Intimal Hyperplastic Response
5. Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances of nanomedicine in treatment of atherosclerosis and thrombosis;Environmental Research;2023-12
2. Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs;Materials Today Bio;2023-10
3. Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities;International Journal of Molecular Sciences;2023-03-08
4. Breakthroughs in nanozyme-inspired application diversity;Materials Chemistry Frontiers;2023
5. Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles;Nanoscale;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3